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Detection of spontaneous abortion in the
periimplantation period is a challenging
problem for reproductive epidemiologists.
This pattern of reproductive failure, which
has been termed early fetal loss (EFL), has
been observed in 22% of pregnancies in
normal unexposed women (1). There is a
strong suspicion that this outcome may be
more frequent when pregnant women are
exposed to reproductive toxicants in the
workplace or other environments (2).
Recognition of EFL in population-based
studies relies primarily on the measurement
of human chorionic gonadotropin (hCG)
in self-collected urine samples (3). The ini-
tial studies of normal women demonstrated
the feasibility of this approach for detecting
EFL (1). However, clinical studies of
research subjects, in which circulating levels
of hCG were measured on a daily basis,
have suggested that in some cases of EFL
there may not be adequate levels of hCG
for detection of pregnancy (4). In popula-
tion-based field studies, false positive detec-
tion of EFL was demonstrated to result
from the presence of hCG in the urine of
nonpregnant women (3).
The complexities involved in detection
of EFL have necessitated the use of other
reproductive biomarkers to minimize the
number of false positive and false negative
results. The application of an assay for
luteinizing hormone and its a subunit
(LH/LH a) has enabled us to identify the
day of ovulation (5), which obviates con-
cerns that false positive results may be
caused by pituitary release of hCG during
the midcycle gonadotropin surge (6,7).
Measurements of urinary pregnanediol-3-
glucuronide (PdG) in combination with
the LH/LH a subunit assay can be used to
recognize the luteal phase of the cycle and
to define an implantation window in which
hCG excretion is likely to be a result of
pregnancy (3). When hCG is detected out-
side of this window, it is unlikely to have
been produced by a conceptus. Despite the
use of multiple biomarkers to detect and
interpret early pregnancy signals, it is still
likely that many pregnancy events will be
missed and that false positive pregnancies
also may be misidentified.
The purpose of the present study was
to investigate the utility of a urinary assay
for follicle stimulating hormone (FSH) as
an additional biomarker for detecting early
pregnancy. The rationale for this approach
is based on our understanding that the
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cedures for
recruitment and insemination of these sub-
jects have been reported previously (4,8).
These subjects are a subset of a larger study
population and were selected for this data
set because they all conceived a pregnancy in
the absence of hormone therapy. Urine sam-
ples were collected by the subjects through-
out the cycle and were frozen immediately
without preservatives in their home refriger-
ator freezer (-10°C). They were delivered to
the laboratory at the end of the cycle and
were stored at -200C. Blood samples were
collected at the clinic by venipuncture
between 10:00 A.M. and 1:00 P.M., begin-
ning on the expected day of ovulation and
continuing until the first day of menses or
until pregnancy was diagnosed by standard
clinical procedures. The samples were
allowed to clot, and the serum was stored
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frozen at -20°C until analyzed. Ten of the
65 cycles that resulted in a normal pregnan-
cy (positive control cycles) provided data
which were used to compare the FSH pro-
files in serum and in urine. Ten healthy
women between the ages of 33 and 47 years
with bilateral tubal ligations (BTL) were
recruited as the nonpregnant control group.
These BTL subjects provided daily serum
samples and early morning urine samples
during one ovulatory menstrual cycle. The
mean values of serum and urinary FSH
concentrations in the BTL group and in the
positive control cycles were compared by
Student's t-test within each day following
the LH peak in serum. All urine samples
had been thawed at least twice prior to the
present study in order to perform other
analyses. Serum measurements ofLH, FSH,
estradiol (E2), progesterone (P), and hCG
were evaluated to document that each cycle
was ovulatory or conceptive.
Assays. Serum FSH, LH, E2 and P con-
centrations were measured using commercial
kits (Diagnostic Products Corp., Los
Angeles, CA). Serum hCG concentrations
were measured by immunoradiometric assay
as described by Lasley et al. (3). The assay for
total urinary FSH, which is based on heat
dissociation of the FSH heterodimer and
measurement of the FSH [ subunit, was per-
formed as follows. Briefly, microtiter plates
(Nunc-Immuno Plate, Maxisorb, Applied
Scientific, San Francisco, CA) were coated
with 200 p1i of 10 pg/mI monoclonal anti-[B
hFSH antibody (FS2-4A10-G1O, Scanti-
bodies Lab, Santee, CA) in 0.2 M sodium
bicarbonate buffer, pH 9.6 , and incubated
for 6 hr or overnight at room temperature
(RT). Unbound sites in the wells were then
blocked by overnight incubation with 250 pl
of 1% casein, 0.05% Tween 20, and 0.1%
sodium azide in 10 mM PBS, pH 7.5. On
the next day, 100 pl of 0.5 M phosphate-
buffered saline (PBS) containing 1% bovine
serum albumin (BSA) and 0.05% sodium
azide, pH 7.5, were added to every well.
Urine samples or internal controls were
transferred to polypropylene minitubes and
placed into boiling water 2 min to dissociate
the FSH subunits. Then, 100 pl treated
urine samples, internal controls or P FSH
subunit standard (provided by the National
Hormone and Pituitary Program) was
added to each assigned well and incubated
overnight at RT. Two hundred microliters
polyclonal rabbit anti-hFSH-[ antisera (9)
was diluted 1:5,000 in buffer B (0.1% [3
gamma globulin, 1% polyethylene glycol
8,000, 0.05% Tween 20, and 10 mM
EDTA in 10 mM PBS) and added to each
well before overnight incubation at RT. The
next day, 200 p1 biotinylated goat anti-rab-
bit IgG (Bio-Rad 170-6401; Bio-Rad,
Richmond, CA) diluted 1:64,000 in buffer B
was added and incubated for 2 hr at RT, fol-
lowed by incubation with 200 p1 of alkaline
phosphatase streptavidin diluted 1:2,000 in
APS buffer (1.0 M NaCl, 0.1% Tween 20 in
10 mM Tris-HCI, pH 7.5) for 1 hr at RT.
Finally, 200 pl of 1 mg/ml p-nitrophenyl
phosphate (pNPP) in substrate buffer (1.0
mM MgCl2, 1.0 M diethanolamine-HCl,
pH 9.0) was added to each well. The plates
were emptied and thoroughly washed with
ELISA wash (0.15 M NaCl plus 0.05%
Tween 20) between each step. Color devel-
opment was expected within 1 hr, and each
plate was read on a microtiter plate reader
(Dynatec Microplate Reader model MR600;
Dynatech Laboratory Inc., Alexandria, VA)
using the dual wavelength mode, 405 nm
minus reference 650 nm. The absorbances
were automatically transferred to an enzyme
immunoassay data reduction program for
curve fitting and data analysis. Urinary con-
centrations ofFSH were indexed by the crea-
tinine concentration in the urine sample (3).
The detection limit (0.32 ng/ml) of the
[ subunit FSH assay was defined as the
concentration corresponding to the mean
plus three standard deviations of zero stan-
dard. For statistical evaluation, concentra-
tions of FSH below the detection limit
were given a value of 0.32 ng/ml. In the
groups of nonconceptive and conceptive
cycles 2.1% and 9.7% of the values were
below the detection limit, respectively.
Urinary FSH algorithm for detection
of conceptive cycles. The development of
the algorithm was based on the change in
FSH secretion that takes place in the luteal
phase of conceptive cycles. In response to
circulating levels of hCG, the ovarian secre-
tion of E2 is increased and, through nega-
tive feedback at the level of the hypothala-
mus and pituitary, the secretion of FSH is
inhibited. In the absence ofhCG, E2 falls in
the late luteal phase and FSH secretion
increases as the hypothalamus and pituitary
are released from negative feedback. A dif-
ference in the slope of change in FSH secre-
tion in the late luteal phase of conceptive
and nonconceptive cycles could therefore be
expected. The slope should be steeper in
nonconceptive cycles than in conceptive
cycles. Urinary FSH concentrations were
indexed by creatinine, and the resulting val-
ues were used to calculate a slope for days
9-14 post serum LH peak in each cycle
using regression analysis. At least four FSH
values from this 6-day interval were
required for calculation of the FSH slope.
To develop the algorithm, the slopes of
urinary FSH concentrations in the 10 posi-
tive control cycles were compared with the
FSH slopes in the 10 cycles from the BTL
group. A cutoff value for the FSH slope
was selected, which correctly classified 9 of
10 cycles in each group as conceptive or
nonconceptive. The algorithm was evaluat-
ed for sensitivity and specificity by compar-
ison to the gold standard of pregnancy
detection by serum hCG. The algorithm
was used to classify the remaining group of
55 artificial insemination cycles. Of these
55 cycles, 11 cycles resulted in a normal
term pregnancy, 10 cycles resulted in a
clinical spontaneous abortion (SAB,
defined as a pregnancy that terminated
after day 23 post LH peak in serum), and 6
cycles resulted in EFL (defined as a preg-
nancy that terminated on or before day 23
post LH peak in serum). The remaining 28
cycles were classified as nonconceptive
because there was no evidence of serum
hCG in the luteal phase of the cycle.
Results
Individual serum profiles of E2, P, LH, and
FSH demonstrated normal follicular phase
lengths, clear evidence of ovulation, and
normal luteal function in both the positive
control cycles and in the BTL cycles (data
not shown). The lengths of the follicular
phases (first day of menstruation until the
LH peak) ranged from 12 to 16 days in the
conceptive cycles and from 10 to 16 days in
the nonconceptive (BTL) cycles and were
not significantly different. Following ovula-
tion, the rise of mean serum P ± standard
error (SE) for the initial 6 days was similar
in the two groups (2.90 ± 0.97 ng/ml/ day
and 2.50 ± 0.98 ng/ml day in conceptive
and nonconceptive cycles, respectively).
The mean profile for total urinary FSH
in the nonconceptive cycles paralleled the
mean serum FSH profile (Fig. 1 A-C). The
FSH profile in serum and in urine was char-
acterized by rising levels in the early follicu-
lar phase, followed by a decline prior to the
midcycle gonadotropin surge. Following the
midcycle surge, there was a gradual decline
in FSH concentrations until approximately
day 10 post LH surge, when luteal phase
levels ofFSH began to rise. This pattern was
dearer in the urinary profile when the FSH
values were indexed by creatinine (Fig IC).
The patterns for mean serum and uri-
nary FSH profiles were similar in the con-
ceptive cycles to those in the nonconceptive
cycles until the midluteal phase, when the
FSH values in conceptive cycles remained
flat rather than rising (Fig. ID-F). This dif-
ference reached statistical significance on
day 10 post LH peak in the serum profile
(Fig. ID) and on day 10 or day 11 in the
urine profile (Fig. lE, F). This effect of
conception was related temporally to the
rise of serum hCG and E2 (Fig. 2) and
coincided with the day when hCG was first
detected in urine (data not shown).
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Urinary FSH values, indexed by creati-
nine, were used to develop an algorithm for
identifying conceptive cycles in the late
luteal phase. The slope of urinary FSH
concentrations between days 9 and 14 post
LH peak ranged from -0.48 to 0.37 ng
FSH/mg creatinine/day in positive control
cycles and was <0.02 in 9 of 10 cycles. In
the BTL cycles, the slope ranged from
-0.02 to 1.55 ng FSH/mg creatinine/day
and was >0.02 in 9 of 10 cycles. Based on
these data, we selected a urinary FSH slope
of >0.02 ng FSH/mg creatinine/day as the
cutoff point for identifying nonconceptive
cycles. Otherwise, the cycle was classified as
conceptive. There was a high concordance
between the day of LH peak in serum and
the day of FSH peak in urine. In the 20
positive and negative control cycles, the
day was the same in 14 cycles (70%), and
the urinary FSH peak was 1 day later than
the serum LH peak in 4 cycles (20%) and
one day earlier in 2 cycles (10%).
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Therefore in applying the algorithm, the
day of FSH peak in urine was used to
determine the days for which the FSH
slope would be calculated, i.e., days 9-14
post FSH peak in urine. In the combined
groups of 75 cycles (controls and
unknowns), the LH peak in serum and the
FSH peak in urine was on the same day in
46 cycles (61.3%), and the urinary FSH
peak was 1 day later in 23 cycles (30.7%)
and 1 day earlier in 6 cycles (8.0%).
When the algorithm was used to dassify
the 55 unknown cycles, 9 of 11 normal con-
ceptive cycles were identified, as well as 15 of
16 cases of spontaneous abortion, induding
the 6 cases of EFL (Table 1). Twenty-five of
28 nonconceptive cycles were also correctly
classified. Therefore, in this sample set the
slope of urinary FSH concentrations in luteal
phase had a sensitivity of 88.9% to detect
pregnancy and a specificity of 89.3%. The
predictive value of a positive test was 88.9%
and the predictive value of a negative test was
12
8
6
12
10
8
6
-6 -4 -2 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28
Days from LH surge Days from LH surge
Figure 1. Mean values ± standard error for serum follicle stimulating hormone (FSH) and total urinary FSH
during 10 nonconceptive cycles (A-C) and 10 conceptive cycles (D-F). FSH values for each day were
compared between nonconceptive and conceptive cycles.
*p<0.05; **p<0.01.
89.3%. The 55 cycles in the unknown sam-
ple set were provided by 35 subjects, four of
whom provided cycles for the set of positive
control samples. Of the remaining 31 sub-
jects, 17 women provided a single cycle, 10
women provided two cycles, three women
provided three cycles and one woman pro-
vided four cycles. To control for the lack of
independence of multiple cycles provided by
the same woman, a subset of single cycles
was selected for testing with the algorithm.
To form this set, all cycles from women who
contributed to the positive control set were
removed. All 17 subjects with single cycles
were induded in the set. When subjects pro-
vided multiple cycles and one of these was an
EFL or SAB, the cycle with failing pregnancy
was selected and the other cycle was
removed. In the case of a subject with both
an EFL and a SAB the cycle with EFL was
selected. For all other subjects, the first cycle
was used and the subsequent cycles were
removed. In the resulting subset of 31 cycles,
18 of 18 conceptive cycles were correctly
identified and 11 of 13 nonconceptive cycles
were dassified correctly. The sensitivity and
specificity of the FSH algorithm to detect
conceptive cycles in the subset of indepen-
dent cycles were 100% and 84.6%, respec-
tively (Table 2).
Discussion
Although much has been written concern-
ing the methods for identification ofEFL in
populations exposed to environmental haz-
ards, there has been limited experience in
detecting this adverse outcome in large-scale
epidemiologic studies. The largest study
undertaken to date involved analysis of
approximately 70,000 daily urine samples,
collected in more than 2,500 menstrual
cycles from 448 women employed in the
semiconductor industry (3). Because of low
fecundability in the study population, con-
clusive results were not obtained in this
investigation (10). Nevertheless, valuable
lessons were learned in the course of this
study regarding the problems and pitfalls of
interpreting urinary biomarkers of reproduc-
tive function in population-based studies.
Based on the results of the initial studies of
EFL in normal women (1), it was believed
that a single assay for urinary hCG would be
sufficient to detect EFL, providing that the
assay was sufficiently sensitive and specific
for the trophoblastic hormone. However, in
the semiconductor study, it was necessary to
use five separate assays for four different
reproductive biomarkers in order to fully
interpret the urinary hormone data (3). A
highly sensitive but relatively nonspecific
screening assay for hCG (11) was used to
eliminate cycles with no evidence of hCG.
Cycles positive for hCG in the screening
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assay were reanalyzed with a specific assay
for heterodimeric hCG (12. Only 21 of the
38 cycles confirmed to be positive for het-
erodimeric hCG were eventually classified as
EFL (3). The detailed analyses of these
cycles involved measurement ofPdG (13) to
confirm that ovulation occurred i
as well as assays for LH/LH a
estrone conjugates (14) to det(
approximate day of ovulation.
hCG was shown to be present in
ry cycle and during the time pt
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E 300-
cm0.
- 200-
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Figure 2. Mean values ± standard error for serum estradiol (E2) and serum human chorionic
(hCG) in 10 nonconceptive cycles (A) and 10 conceptive cycles (B).
Table 1. Sensitivity and specificity of total urinary follicle stimulating hormone (FSH) to detect conc
Pregnancy outcome
Slope of FSH concentrations Conceptive
days 9-14 post FSH peak Normal pregnancy EFL SAB Nonconceptive
Conceptive cycle
(<0.02 ng FSH/mg creatinine/day) 9 6 9 3
Nonconceptive cycle
(>0.02 ng FSH/mg creatinine/day) 2 0 1 25
11 6 10 28
Abbreviations: EFL, early fetal loss; SAB, spontaneous abortion; Cl, confidence interval.
Sensitivity (95% Cl) = 88.9% (77.8-101.0); specificity (95% Cl) = 89.3% (83.5-95.1); predictive va
tive test (95% Cl) = 88.9% (77.8-101.0); predictive value of a negative test (95% Cl) = 89.3% (83.
in the cycle, implantation could take place was the cycle
(5) and/or classified as having EFL (3).
ermine the The assay for total urinary FSH, which
Only when we have used in this study, provides an
an ovulato- additional biomarker for early pregnancy.
eriod when Like the changes in the ovarian steroid hor-
mones E2 and P and in the peptide hor-
mone relaxin, the change in FSH secretion
that takes place in the luteal phase of con-
ceptive cycles results from the presence of
-8 circulating hCG and is a biological response
to the pregnancy signal. The results of the
-_ present study suggest that this biomarker
-6E has good sensitivity for detecting early preg-
nancies, including those that terminate in
EFL. Declining concentrations of FSH
-4 E between 9 and 14 days post FSH peak are
not sufficient evidence alone that concep-
tion has occurred because other factors
-
2 could be responsible for this outcome. For
example, acute physical or emotional stress
could prevent or delay the expected rise of
0° FSH and give the appearance of FSH sup-
pression due to pregnancy. However, when
immunoreactive hCG has been detected in
a cycle, the failure of FSH to rise following
the midcycle gonadotropin surge indicates
10 that there has also been an ovarian response
to a gonadotropic signal. This evidence of
bioactivity is important for evaluation of
L8 transient low concentrations of hCGimmunoactivity in urine samples.
Because FSH is released together with
LH during the preovulatory gonadotropin
surge, the FSH profile also provides infor-
Ca mation on the approximate day of ovulation
and can be used to locate the implantationE4 E window. In our sample set, the peak of
CAX FSH in urine was on the same day as the
LH peak in serum in more than 60% of
2 cycles, and the two events were never more
than 1 day apart. Our results suggest that
the urinary FSH biomarker, in conjunction
0
with measurements of urinary hCG, may
0 be sufficient to demonstrate most EFL
!8 events. Cycles that demonstrate a clear
gonadotropin surge and a rise of hCG in
the implantation window, but no suppres-
gonadotropin sion of FSH, would require evaluation with
other biomarkers. Either ovarian dysfunc-
tion or an abnormality of hypothalamic-
,eptive cycles pituitary function could result in such an
outcome. However, measurements of ovar-
ian steroid metabolites, such as estrone
conjugates and PdG, would distinguish
Total between these alternative explanations. The
combination of a normal nonconceptive
27 steroid hormone profile and a normal non-
conceptive FSH profile would lead to the
28 conclusion that the hCG was not of tro-
55 phoblastic origin and that the cycle must
be classified as nonconceptive. Our experi-
lue of a posi- ence to date indicates that the presence of
.5-95.1). hCG in nonconceptive cycles should be
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Table 2. Sensitivity and specificity of total urinary follicle stimulating hormone (FSH) to detect conceptive
cycles in a subset of cycles in which each subject contributed a single cycle
Pregnancy outcome
Slope of FSH concentrations Conceptive
days 9-14 post FSH peak Normal pregnancy EFL SAB Nonconceptive Total
Conceptive cycle
(<0.02 ng/mg creatinine/day) 6 5 7 2 20
Nonconceptive cycle
(>0.02 ng/mg creatinine/day) 0 0 0 11 11
6 5 7 13 31
Abbreviations: EFL, early fetal loss; SAB, spontaneous abortion; Cl, confidence interval.
Sensitivity (95% Cl) = 100% (100-100); specificity (95% Cl) = 84.6% (65.3-103.9); predictive value of a posi-
tive test (95% Cl) = 90% (83.3-96.7); predictive value of a negative test (95% Cl) = T00% (100-100).
anticipated in any large-scale epidemiologic
study of pregnancy wastage (3). However,
in all such cases identified so far, the hCG
was not found within an implantation win-
dow (3). Thus, there may be little necessity
of employing additional biomarkers in
hCG-positive cycles as long as the FSH
peak can be identified and the FSH profile
can be clearly interpreted as either normal
or abnormal.
While the focus of this report is on
pregnancy detection, the assay for total uri-
nary FSH also can be used to evaluate ovar-
ian function in nonconceptive cycles. The
initiation of the next ovarian cycle is
dependent on the release of pituitary sup-
pression from the negative feedback of
ovarian steroids in the luteal phase of the
cycle. The resultant rise of FSH in the
midluteal phase of the antecedent ovarian
cycle is the initiator of the follicular phase
of the following cycle. When this rise of
FSH is absent or delayed, the recruitment
of follicles for the next cycle will likewise
be delayed. This outcome would be associ-
ated with an increase in the length of follic-
ular phase and a period of hypoestrogenism
that could be prolonged. Studies are cur-
rently in progress that utilize the total uri-
nary FSH assay to detect perturbations of
FSH secretion and the adverse effects of
such events on ovarian function.
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